New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 12, 2014
07:41 EDTRDUSRadius Health reports Q2 EPS ($2.22), may not compare to consensus (89c)
The net loss per share calculation for the three months ended June 30 includes the weighted average impact of Radius' convertible preferred stock converting into common stock upon the completion of its initial public offering in June. The decrease in net loss for the 2014 period was primarily due to a decrease in research and development expenses.
News For RDUS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 10, 2014
07:51 EDTRDUSRadius Health price target raised to $30 from $26 at Canaccord
Canaccord raised its price target on Radius Health to $30 from $26 to reflect the company's drug potential for brain metastases. The firm noted continued positive data from its trials will contribute to long term upside for the shares. Canaccord reiterates its Buy rating on Radius Health.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use